Synonyms: UCB 35625 | UCB-35625
Compound class:
Synthetic organic
Comment: UCB35625 is a potent and selective dual antagonist of the chemokine receptors CCR1 and CCR3 [2]. May be used experimentally as the iodide salt.
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
References |
1. Laurent V, Guérard A, Mazerolles C, Le Gonidec S, Toulet A, Nieto L, Zaidi F, Majed B, Garandeau D, Socrier Y et al.. (2016)
Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity. Nat Commun, 7: 10230. [PMID:26756352] |
2. Sabroe I, Peck MJ, Van Keulen BJ, Jorritsma A, Simmons G, Clapham PR, Williams TJ, Pease JE. (2000)
A small molecule antagonist of chemokine receptors CCR1 and CCR3. Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry. J Biol Chem, 275 (34): 25985-92. [PMID:10854442] |